| Old Articles: <Older 22281-22290 Newer> |
 |
The Motley Fool April 17, 2007 Rick Aristotle Munarriz |
InsWeb Turns Over a New Leaf The online insurance lead generator finally turns an operating profit. But investors may want to wait another quarter or two for validation here, if only because the cash cushion is now so far away.  |
The Motley Fool April 17, 2007 Matt Koppenheffer |
How Much Is Goldman Sachs Really Worth? An analyst takes apart Goldman's business segments to give a perspective on how the brokerage giant could be valued.  |
The Motley Fool April 17, 2007 Rich Duprey |
Cutter & Buck's New Threads The upscale golf-apparel retailer agrees to be acquired by a Swedish corporate-gift firm. Investors, take note.  |
The Motley Fool April 17, 2007 Ryan Fuhrmann |
Many Moving Parts at KeyCorp: Fool by Numbers The bank released earnings for the first-quarter 2007: Income Statement Highlights... Ratio Checkup... Balance Sheet Highlights...  |
The Motley Fool April 17, 2007 |
Mattel Tells a Good Story: Fool by Numbers The toy maker released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool April 17, 2007 Anders Bylund |
3 Stocks That Missed the Mark A peek at companies that over-promised and under-delivered: Electro Scientific Industries... Krispy Kreme Doughnuts... Keithley Instruments...  |
The Motley Fool April 17, 2007 Rich Smith |
Foolish Forecast: Champion on Deck The manufactured housing company reports its first-quarter 2007 shortly. Investors, here is what you can expect to see.  |
The Motley Fool April 17, 2007 Brian Lawler |
ImClone Loses an Indication ImClone's lead drug fails in a clinical trial. Investors, take note.  |
The Motley Fool April 17, 2007 Mike Cianciolo |
Gymboree's Comps Jump The kids' apparel retailer reported strong sales growth for March on top of last year's gains. Investors, take note.  |
The Motley Fool April 17, 2007 Rick Aristotle Munarriz |
When the Carnival Leaves Town The cruise-line giant offers healthier dividends, but looks abroad for growth. Investors, take note.  |
| <Older 22281-22290 Newer> Return to current articles. |